News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,686 Results
Type
Article (2697)
Company Profile (39)
Press Release (37950)
Section
Business (14980)
Career Advice (84)
Deals (2252)
Drug Delivery (9)
Drug Development (4355)
Employer Resources (10)
FDA (497)
Job Trends (842)
News (21497)
Policy (1159)
Tag
Academia (160)
Alliances (3652)
Alzheimer's disease (52)
Antibody-drug conjugate (ADC) (14)
Approvals (499)
Bankruptcy (12)
Best Places to Work (528)
Biosimilars (10)
Biotechnology (29)
Breast cancer (15)
Cancer (109)
Career advice (69)
CAR-T (12)
Cell therapy (35)
Clinical research (3365)
Collaboration (84)
Compensation (36)
COVID-19 (180)
C-suite (21)
Data (90)
Diagnostics (531)
Earnings (4505)
Events (6253)
Executive appointments (76)
FDA (536)
Funding (70)
Gene editing (13)
Gene therapy (16)
GLP-1 (59)
Government (168)
Healthcare (773)
Infectious disease (185)
Inflammatory bowel disease (11)
Intellectual property (10)
Interviews (9)
IPO (1063)
Job creations (321)
Job search strategy (66)
Layoffs (37)
Legal (234)
Lung cancer (16)
Manufacturing (21)
Medical device (366)
Medtech (366)
Mergers & acquisitions (1241)
Metabolic disorders (27)
Neuroscience (95)
NextGen: Class of 2025 (376)
Non-profit (173)
Northern California (294)
Obesity (13)
Opinion (17)
Patents (15)
People (5842)
Phase I (1403)
Phase II (1671)
Phase III (960)
Pipeline (50)
Postmarket research (32)
Preclinical (597)
Radiopharmaceuticals (13)
Rare diseases (17)
Real estate (486)
Regulatory (860)
Research institute (152)
Resumes & cover letters (11)
Schizophrenia (14)
Series A (22)
Southern California (306)
Startups (507)
United States (1431)
Vaccines (24)
Weight loss (9)
Date
Today (16)
Last 7 days (61)
Last 30 days (197)
Last 365 days (2698)
2025 (340)
2024 (2754)
2023 (3040)
2022 (3948)
2021 (4312)
2020 (3718)
2019 (2307)
2018 (1730)
2017 (1926)
2016 (1790)
2015 (1994)
2014 (1480)
2013 (1318)
2012 (1539)
2011 (1460)
2010 (1282)
Location
Africa (49)
Arizona (14)
Asia (2015)
Australia (339)
California (692)
Canada (123)
China (32)
Colorado (15)
Connecticut (12)
Europe (4129)
Florida (40)
Illinois (14)
Indiana (29)
Kansas (12)
Maryland (22)
Massachusetts (238)
Minnesota (15)
New Jersey (49)
New York (40)
North Carolina (81)
Northern California (294)
Ohio (24)
Pennsylvania (32)
South America (53)
Southern California (306)
Texas (54)
Washington State (36)
40,686 Results for "sola biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
SOLA Biosciences Presents Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS, at Neuroscience 2023 and ALS One Symposium
As a pioneer in innovative chaperone technology, SOLA Biosciences Inc. will present its compelling preclinical proof-of-concept data for SOL-257, a targeted gene therapy for misfolded TDP-43 in Amyotrophic Lateral Sclerosis, at Neuroscience 2023 in Washington, D.C. on November 15 and the ALS One Symposium on November 17.
November 9, 2023
·
2 min read
Genetown
SOLA Biosciences Shares Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS at 22nd Annual NEALS Meeting
SOLA Biosciences, a pioneer in innovative chaperone technology, will present its encouraging preclinical proof-of-concept data for SOL-257, a targeted gene therapy for misfolded TDP-43 in ALS, at the 22nd Annual Northeast ALS Consortium (NEALS) Meeting held in Florida on October 5.
October 3, 2023
·
2 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Chromatin Bioscience Joins JLABS EMEA
February 20, 2025
·
2 min read
Press Releases
EnPlusOne Biosciences Raises $10M in Financing
February 19, 2025
·
3 min read
Press Releases
Solid Biosciences Announces Pricing of Underwritten Offering
February 18, 2025
·
5 min read
Press Releases
MBX Biosciences to Participate in March 2025 Investor Conferences
February 19, 2025
·
1 min read
Press Releases
NAYA Biosciences Announces Nomination of New Board Members
February 19, 2025
·
6 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - February 11, 2025
February 12, 2025
·
2 min read
Press Releases
Skye Bioscience Announces Participation in February Conferences
February 4, 2025
·
2 min read
1 of 4,069
Next
